Abstract
Atrial fibrillation and heart failure impose substantial health burdens worldwide, yet existing prediction models lack sufficient accuracy and generalizability. We developed CARDIAC-FM, a multimodal foundation model that learns joint representations of 12-lead electrocardiogram (ECG) and cardiac magnetic resonance imaging (MRI) through contrastive learning. We trained CARDIAC-FM on 57,609 paired ECG-cardiac MRI samples from UK Biobank and evaluated it in two external cohorts: the Cardiovascular Health Study (CHS) and the Multi-Ethnic Study of Atherosclerosis (MESA). CARDIAC-FM consistently outperformed unimodal models across all cohorts, and jointly incorporating ECG features with established clinical risk scores yielded additive gains in discrimination, indicating that ECG and traditional risk factors capture complementary dimensions of cardiovascular risk. The learned representations improved prediction across a range of cardiovascular outcomes with minimal task-specific fine-tuning, reflecting real-world settings where many diseases have limited positive samples and lack dedicated risk models. Although trained on paired ECG and MRI data, CARDIAC-FM generates predictions using ECG alone or ECG combined with established risk scores, enabling broad clinical deployment without MRI. These findings demonstrate the promise of multimodal pre-training for generalizable cardiovascular risk prediction.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
UK Biobank data are made available to researchers from research institutions as described at this site: https://www.ukbiobank.ac.uk/enable-your-research. Data for Cardiovascular Health Study and Multi-Ethnic Study of Atherosclerosis can be requested at https://internal.mesa-nhlbi.org/ and https://chs-nhlbi.org/node/6222, respectively. The datasets used in the study were individual-level data that had been de-identified prior to use.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
↵# Joint last author
Data availability
UK Biobank data are made available to researchers from research institutions as described at this site: https://www.ukbiobank.ac.uk/enable-your-research. Data for Cardiovascular Health Study and Multi-Ethnic Study of Atherosclerosis can be requested at https://internal.mesa-nhlbi.org/ and https://chs-nhlbi.org/node/6222, respectively.
